ARS Pharmaceuticals, Inc.(SPRY)

Biotechnology · San Diego, CA

$4.29-0.00 (-0.12%)

Delayed quote: Oct 6, 2026, 3:10 PM EDT

Compare

PE Ratio: N/A

Name: ARS Pharmaceuticals, Inc. (SPRY) PE Ratio — historical time series
Creator: TGMCharts

Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

The P/E ratio is N/A as of 2026-10-06T19:13:41.322Z.

Stored calculation inputs

Calculation as of: 2026-10-06T19:13:41.322Z.

Quote observation: 2026-10-06T19:10:20.000Z. Amounts in USD. The price header may show a later quote.

Quote price: 4.285
Unrounded diluted TTM EPS · period ending 2026-06-30: -2.18

FMP input reference: 245dd754b0f03b0474a1f4d6c5429d137941524b53a54e0755d3e87780725df6

Forward PE Ratio|PEG Ratio|P/B Ratio|EPS|All Metrics

PE Ratio

SPRY PE Ratio Chart

N/A

SPRY PE Ratio Metrics

PE RATIO

N/A

PE RATIO AVG TTM

N/A

PE RATIO AVG 3Y

N/A

PE RATIO AVG 5Y

N/A

PE RATIO AVG 10Y

N/A

PE RATIO AVG 15Y

N/A

PE RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

N/A

CURRENT VS 3Y AVG

N/A

CURRENT VS 5Y AVG

N/A

CURRENT VS 10Y AVG

N/A

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

SPRY Competitors' PE Ratio

SPRY

ARS Pharmaceuticals, Inc.

Current

Market Cap

$425.51M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

TLRY

Tilray Brands, Inc.

vs SPRY

Market Cap

$426.64M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NEO

NeoGenomics, Inc.

vs SPRY

Market Cap

$425.51M

PE Ratio

N/A

TTM Avg

138.05

3Y Avg

184.03

5Y Avg

168.06

PRTA

Prothena Corporation plc

vs SPRY

Market Cap

$424.45M

PE Ratio

N/A

TTM Avg

33.09

3Y Avg

33.09

5Y Avg

33.09

EDIT

Editas Medicine, Inc.

vs SPRY

Market Cap

$429.69M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SENS

Senseonics Holdings, Inc.

vs SPRY

Market Cap

$418.57M

PE Ratio

N/A

TTM Avg

7.35

3Y Avg

7.35

5Y Avg

7.35

TECX

Tectonic Therapeutic, Inc.

vs SPRY

Market Cap

$437.36M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

EIKN

Eikon Therapeutics, Inc. Common Stock

vs SPRY

Market Cap

$413.62M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MPLT

MapLight Therapeutics, Inc.

vs SPRY

Market Cap

$411.32M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ASMB

Assembly Biosciences, Inc.

vs SPRY

Market Cap

$439.84M

PE Ratio

40.35

TTM Avg

54.06

3Y Avg

54.06

5Y Avg

54.06

NAME	MARKET CAP	PE RATIO	TTM	3Y	5Y
ARS Pharmaceuticals, Inc. (SPRY)	$425.51M	N/A	N/A	N/A	N/A
Tilray Brands, Inc. (TLRY)vs ›	$426.64M	N/A	N/A	N/A	N/A
NeoGenomics, Inc. (NEO)vs ›	$425.51M	N/A	138.05	184.03	168.06
Prothena Corporation plc (PRTA)vs ›	$424.45M	N/A	33.09	33.09	33.09
Editas Medicine, Inc. (EDIT)vs ›	$429.69M	N/A	N/A	N/A	N/A
Senseonics Holdings, Inc. (SENS)vs ›	$418.57M	N/A	7.35	7.35	7.35
Tectonic Therapeutic, Inc. (TECX)vs ›	$437.36M	N/A	N/A	N/A	N/A
Eikon Therapeutics, Inc. Common Stock (EIKN)vs ›	$413.62M	N/A	N/A	N/A	N/A
MapLight Therapeutics, Inc. (MPLT)vs ›	$411.32M	N/A	N/A	N/A	N/A
Assembly Biosciences, Inc. (ASMB)vs ›	$439.84M	40.35	54.06	54.06	54.06

P/E Comparison

Trailing P/E

N/A

Forward P/E

N/A

Forward P/E Calculation

View All Analyst Estimates

Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.

Calculation:

Current Price

$4.29

Forward EPS (Est.)

$-1.78

Forward P/E

N/A

Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.

PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

SPRY PE Ratio History

DATE	PE RATIO
2025-05-14	172.86
2025-05-13	190.71
2025-05-12	189.86
2025-05-09	192.00
2025-05-08	192.71
2025-05-07	192.71
2025-05-06	200.29
2025-05-05	203.71
2025-05-02	206.57
2025-05-01	202.29
2025-04-30	199.57
2025-04-29	198.86
2025-04-28	202.00
2025-04-25	196.71
2025-04-24	209.14
2025-04-23	205.43
2025-04-22	214.29
2025-04-21	204.57
2025-04-17	212.57
2025-04-16	212.57
2025-04-15	214.14
2025-04-14	206.71
2025-04-11	200.71
2025-04-10	189.14
2025-04-09	190.57
2025-04-08	176.14
2025-04-07	183.29
2025-04-04	182.86
2025-04-03	191.43
2025-04-02	186.43
2025-04-01	179.00
2025-03-31	179.71
2025-03-28	178.43
2025-03-27	180.43
2025-03-26	180.00
2025-03-25	187.86
2025-03-24	184.14
2025-03-21	176.57

See the Lowest P/E Ratio Stocks ranking →

PE Ratio: N/A

SPRY PE Ratio Chart

SPRY PE Ratio Metrics

SPRY Competitors' PE Ratio

P/E Comparison

Forward P/E Calculation

PE Ratio Formula & Definition

SPRY PE Ratio History

Related Metrics